A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery
B. I. ERIKSSON, A. G. G. TURPIE, M. R. LASSEN, M. H. PRINS, G. AGNELLI, P. KÄLEBO, M. L. GAILLARD, L MEEMS, FOR THE ONYX STUDY GROUPVolume:
5
Year:
2007
Language:
english
Pages:
6
DOI:
10.1111/j.1538-7836.2007.02644.x
File:
PDF, 569 KB
english, 2007